Navigation Links
Caldolor® Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Date:5/16/2011

NASHVILLE, Tenn., May 16, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that results from a clinical study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research. The study demonstrated that Caldolor significantly reduces fever in these patients, including those with severe thermal burns. The newly published study also supports the safety of Caldolor as it involved the highest dose and duration of exposure to IV ibuprofen to date, demonstrating that the recommended maximum daily dose of 3200mg/day over five days of treatment was well tolerated.

"Immediate and sustained regulation of body temperature and reduction of fever following a burn injury is critical to patient recovery as well as comfort," said Dr. John T. Promes, principal investigator of the study, Director of Trauma Services and Associate Director for Surgical Education at Orlando Regional Medical Center, Assistant Professor of Surgery at the University of Central Florida College of Medicine, and Clinical Assistant Professor in the Department of Surgery at the Florida State University College of Medicine. "Because oral administration of antipyretics in hospitalized burn patients is often impossible due to sedation, intubation and a variety of factors, IV fever reduction with an agent such as Caldolor is not only convenient but often necessary. Further, as a non-steroidal anti-inflammatory drug (NSAID), Caldolor has the potential to arrest the cascade of inflammation caused by burn injury and thereby alleviate pain in addition to fever."

The prospective, multicenter, randomized, double-blind, placebo-controlled trial was conducted at five U.S. and international sites, including hospital burn units and burn centers. The study evaluated 61 adult
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
2. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
3. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
4. Caldolor® (ibuprofen) Injection Gaining Approval on Formulary at U.S. Medical Centers
5. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
6. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
7. Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
8. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
9. Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society
10. Medco Research Institute® and AssureRx Health Initiate Pilot Program to Evaluate Adoption and Clinical Impact of Pharmacogenetic Testing for Selection of Psychotropic Medications
11. MedQuist Awarded Clinical Documentation Outsource Contract for St. Josephs Hospital Health Center With Focus on Cost Savings, Quality, Peace of Mind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Physician Office Laboratory Markets, 3rd Edition" ... report, Physician Office Laboratory Markets is Kalorama,s complete ... industry. Physician office laboratories are diverse in their ... reimbursable, in-office pregnancy and glucose tests. Some specialty ...
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... 2014  SiteOne Therapeutics Inc. today announced the completion ... Sears Capital Management and Biobrit LLC, with additional investors ... $1.5 million financing positions SiteOne to advance its oral ... further develop its technology platform for long-acting local analgesics, ... conjunction with the financing, Lowell Sears (Sears ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... New study questions ability of human-animal hybrids to generate ... Cell Technology, Inc. (OTC Pink Sheets: ACTC) and its ... the capacity to extensively reprogram adult human cells. The ... journal Cloning and Stem Cells (Editor-in-Chief: Sir ...
... Inc., the leader in the,development of devices for ... start of enrollment in the REALISM (Real World ... continued access,registry. The MitraClip(R) system is currently being ... option for patients suffering from the,effects of mitral ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5First U.S. Patients Enrolled in the REALISM Continued Access Study 2First U.S. Patients Enrolled in the REALISM Continued Access Study 3
(Date:9/23/2014)... Academia Sinica, the preeminent academic institution in the ... collaborative agreement to develop a unique educational and ... opportunities to translate innovative technologies and commercially relevant ... signed Sept.12 in Taipei by Harris Lewin, vice ... Chi-Huey Wong of Academia Sinica. The program will ...
(Date:9/23/2014)... San Diego, CA (PRWEB) September 23, 2014 ... website daily regarding all the latest information from the ... announced on September 5, that its Private Label Jalapeno ... glass and small stones. Publix Jalapeno Bagels ... in the bakery department. , Taking into consideration ...
(Date:9/23/2014)... Kathleen Doheny HealthDay Reporter ... babies born at very low birth weights, breast milk is ... potentially dangerous infection known as cytomegalovirus (CMV), a new study ... birth weight infants -- all of whom weighed 3.3 pounds ... a history of CMV infection, to see whether breast milk ...
(Date:9/23/2014)... (HealthDay News) -- Both drinking and getting drunk at ... abuse by high school students, a new study suggests. ... school students who drink, could help expand alcohol-prevention efforts ... to stop them from becoming binge drinkers, the researchers ... first alcohol use and progression to first heavy use ...
(Date:9/23/2014)... Washington, DC (PRWEB) September 23, 2014 ... affordable care? The National Quality Forum (NQF) ... sheet ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( ... the rising cost of healthcare, how patients define ... for consumers to get the best possible healthcare ...
Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Publix Private Label Jalapeno Bagels Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2
... In response to the recent media attention on ... Williamsburg Place , one of the nation,s leading addiction treatment ... Omar S. Manejwala, M.D., Associate Medical Director for the Farley Center ... area and has appeared nationally recently on programs such as the ...
... WORCESTER, Mass., July 17 The Hanover Insurance Group (NYSE: ... announced the availability of a new product offering that can extend homeowners ... , , (Logo: ... The coverage is more important than ever as the population of people ...
... temperament, study finds , FRIDAY, July 17 (HealthDay News) -- ... may have nothing to do with your parenting skills because ... of brain activity may determine a child,s temperament, a new ... the DRD4 gene and activity in the frontal cortex of ...
... N.C., July 17 Rabies is a virus that occurs in mammals ... humans if it is not treated. Nearly 90 percent of cases occur ... occur in domestic animals like dogs or cats. Humans usually become infected ... , Early symptoms of rabies are fever, headache and ...
... , , , GLASGOW, ... the UK would most like to be the national emblem of England, ... comes from a new survey commissioned by AXA PPP healthcare,s Nutrition and ... the EU lifted its ban on the sale of ,misshapen, produce such ...
... The ... Partner at the law firm of Loeb & Loeb LLP, as Chair, and Sheldon Kwiat, President ... ... YAI/National Institute for People with Disabilities (YAI/NIPD) Board of Trustees has elected Eliot Green, a ...
Cached Medicine News:Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 2Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 3Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 3Health News:Easy Baby or Fussy -- It May Be Out of Mom's Control 2Health News:Rabies: How to Protect Yourself and Your Pets 2Health News:Potato Tops Poll To Be UK's National Veg 2Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 2Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 3Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 4
0.5mm "K" hook. Rounded knurled handle; shaft angled 11mm from tip; overall length 120mm, in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
... The eSpeed C300 uses its hallmark 50 and ... techniques. New MultiPhase scan protocols and proprietary ... C300s four beam targets and two x-ray detector ... arteries and analyze myocardial perfusion and wall motion. ...
Medicine Products: